Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
A deep dive into testing and management of COVID-19 for Australian high performance and professional sport
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
A deep dive into testing and management of COVID-19 for Australian high performance and professional sport
Creator
Gov,
Hughes, David
Au,
Broderick, Carolyn
Kanthi, Nirmala
Mooney, Mathew
Perera, Panagodage
Saw, Richard
Wallett, Alice
Drew, Michael
Mooney@ausport, Mathew
Orcid, (
Waddington, Gordon
Source
Elsevier; Medline; PMC
abstract
Abstract The purpose of testing for any communicable disease is to support clinicians in the diagnosis and management of individual patients and to describe transmission dynamics. The novel coronavirus is formally named SARS-CoV-2 and the clinical disease state resulting from an infection is known as COVID-19. Control of the COVID-19 pandemic requires clinicians, epidemiologists, and public health officials to utilise the most comprehensive, accurate and timely information available to manage the rapidly evolving COVID-19 environment. High performance sport is a unique context that may look towards comprehensive testing as a means of risk mitigation. Characteristics of the common testing options are discussed including the circumstances where additional testing may be of benefit and considerations for the associated risks. Finally, a review of the available technology that could be considered for use by medical staff at the point of care (PoC) in a high-performance sporting context is included.
has issue date
2020-05-07
(
xsd:dateTime
)
bibo:doi
10.1016/j.jsams.2020.05.005
bibo:pmid
32418804
has license
els-covid
sha1sum (hex)
d3fd25a3bc16d7979dfef636ab153fc00bcefd95
schema:url
https://doi.org/10.1016/j.jsams.2020.05.005
resource representing a document's title
A deep dive into testing and management of COVID-19 for Australian high performance and professional sport
has PubMed Central identifier
PMC7204746
has PubMed identifier
32418804
schema:publication
J Sci Med Sport
resource representing a document's body
covid:d3fd25a3bc16d7979dfef636ab153fc00bcefd95#body_text
is
schema:about
of
named entity 'environment'
named entity 'manage'
named entity 'care'
named entity 'clinicians'
named entity 'high'
named entity 'COVID-19'
named entity 'WHERE'
named entity 'TIMELY'
named entity 'ADDITIONAL'
named entity 'SPORT'
named entity 'MANAGEMENT'
named entity 'DYNAMICS'
named entity 'OPTIONS'
named entity 'TO SUPPORT'
named entity 'INDIVIDUAL'
named entity 'MITIGATION'
named entity 'comprehensive'
named entity 'public health'
named entity 'transmission'
named entity 'sporting'
named entity 'management'
named entity 'coronavirus'
named entity 'COVID-19'
named entity 'PCR'
named entity 'virus'
named entity '8 days'
named entity 'antibodies'
named entity 'COVID'
named entity 'clinical findings'
named entity 'cross reactivity'
named entity 'asymptomatic'
named entity 'probability'
named entity 'COVID-19'
named entity 'pre-test probability'
named entity 'infectious diseases'
named entity 'SARS-COV-2'
named entity 'infection'
named entity 'quantitative polymerase chain reaction'
named entity 'high-risk'
named entity 'enzyme-linked immunosorbent assay'
named entity 'PCR'
named entity 'pathology'
named entity 'pathogen'
named entity 'testing kits'
named entity 'false negative'
named entity 'COVID-19 tests'
named entity 'SARS-CoV-2'
named entity 'rapid antigen test'
named entity 'lung'
named entity 'clinical testing'
named entity 'COVID-19'
named entity 'virus'
named entity 'cruise ship'
named entity 'false positive'
named entity 'IgM'
named entity 'biopsy'
named entity 'reverse transcription'
named entity 'asymptomatic'
named entity 'lung'
named entity 'PCR'
named entity 'false negative'
named entity 'epidemiological'
named entity 'bioMérieux'
named entity 'Testing facilities'
named entity 'medical service'
named entity 'team physician'
named entity 'Zika virus'
named entity 'PCR testing'
named entity 'SARS-CoV-2'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software